Tepthera AG

Swiss Biotech Association

Member

Tepthera is a spin off from the ETH Zurich focusing on product development in the field of cancer immunotherapy, autoimmune- and infectious diseases.

http://www.tepthera.com
+41 79 176 39 18
fjo@tepthera.com
PhD Franz-Josef Obermair

Location

Wagistrasse 47, 8952 Schlieren, Switzerland

Facts & figures

Type of organization

Private company
Year of foundation

2018
Number of employees in Switzerland

1-9

Key business

Core competencies

Platform technologies

You may also be interested in

TissueLabs Sagl

TissueLabs is the platform for <strong>creating organs and tissues in the lab</strong>. We offer <strong>biomaterials, equipment, and services</strong> to support tissue engineering and regenerative medicine. <strong>Our mission is to fabricate lab-grown tissues and organs</strong>, for both research and therapeutic applications.
Via Cantonale 18

Limula SA

Limula SA is developing a platform technology to enable scale out of cell therapy manufacturing, directly at the point of care. We support companies at all stages of the life cycle of their therapies, from R&D to routine production.
La Tour-de-Peilz

SIX

The Swiss Stock Exchange, representing more than a third of the European life sciences market capitalization and accounting for around 35% of the total market capitalization (as of 7 April 2021), the exchange is one of Europe’s leading listing venues for biotech companies.
Zürich